We may attribute these controversial findings to the fact that most investigations assessing PD-1 expression in COVID-19 have studied patients treated with several drug cocktails, including cyclooxygenase (COX)-inhibitors, dexamethasone, anticoagulants, among others (32, 33). The gene discussed is PDCD1; the disease is COVID-19.